COMPASS PATHWAYS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.94 USD | +1.02% |
|
-5.25% | -9.26% |
| 04-18 | Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing | MT |
| 04-18 | Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing | MT |
Chart calendar COMPASS Pathways plc
370fff9e0d79e25959d5bb0c034a1b3._kN6RIwbb3oYjIeyDmA3DRSQyTLMObzqCdPh9xmSJlU.hwUJLvpZWw0uyMX-dCZ-NSbbrnSPAM2AQIzYw3L4VBe8Ej082SgZDVu_4A~abd4cc29e0d3bea6786c835ec0bcc987
Upcoming events on COMPASS Pathways plc
Past events on COMPASS Pathways plc
| 29/02/2024 13:00 | Q4 2023 Earnings Call |
| 29/02/2024 12:00 | Q4 2023 Earnings Release |
| 02/11/2023 12:00 | Q3 2023 Earnings Call |
| 02/11/2023 11:00 | Q3 2023 Earnings Release |
| 27/09/2023 14:45 | Cantor Global Healthcare Conference |
| 11/09/2023 20:30 | H.C. Wainwright Global Investment Conference |
| 03/08/2023 13:00 | Q2 2023 Earnings Call |
| 03/08/2023 12:00 | Q2 2023 Earnings Release |
| 11/07/2023 13:00 | Business Update Call |
| 04/06/2023 | American Society of Clinical Oncology Conference |
| 02/06/2023 13:30 | Annual General Meeting |
| 11/05/2023 13:00 | Q1 2023 Earnings Call |
| 11/05/2023 12:00 | Q1 2023 Earnings Release |
| 19/04/2023 14:30 | Needham Healthcare Conference |
| 13/03/2023 | Loop Capital Investor Conference |
| 13/03/2023 14:00 | Oppenheimer Healthcare Conference |
| 06/03/2023 17:50 | Cowen Health Care Conference - Panel |
| 28/02/2023 13:00 | Q4 2022 Earnings Call |
| 28/02/2023 12:00 | Q4 2022 Earnings Release |
| 30/11/2022 14:15 | Evercore ISI HealthCONx Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -51,3 -53,1 3.36% | -83,0 -77,6 -7.03% | -110 -107 -2.43% | -137 -127 -7.85% | -154 |
|
EBIT Million USD | Released Forecast Spread | -21,2 | -51,4 -52,9 2.92% | -83,2 -76,0 -9.49% | -110 -107 -2.77% | -137 -127 -7.57% | -162 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -60,3 -54,4 -10.78% | -71,5 -66,4 -7.74% | -91,1 -88,0 -3.51% | -118 -107 -9.96% | -152 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -60,3 -54,5 -10.7% | -71,7 -66,5 -7.92% | -91,5 -88,3 -3.61% | -118 -107 -10.35% | -152 |
|
EPS USD | Released Forecast Spread | -0,35 | -3,55 -2,13 -66.67% | -1,79 -1,67 -7.06% | -2,16 -2,07 -4.12% | -2,32 -2,22 -4.37% | -2,19 |
| Announcement Date | 02/07/20 | 09/03/21 | 24/02/22 | 28/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -28,3 -22,7 -24.54% | -25,4 -31,1 18.31% | -27,2 -28,7 5.36% | -25,4 -30,0 15.26% | -32,1 -30,4 -5.69% | -31,7 -32,4 1.89% | -32,6 -31,9 -2.05% | -33,9 -24,5 -38.27% | -38,5 -25,5 -51.01% | -30,8 | -38,6 | -39,6 | -40,7 |
|
EBIT Million USD | Released Forecast Spread | -28,3 -21,3 -33.12% | -25,4 -29,5 13.68% | -27,3 -27,0 -1.14% | -25,5 -29,1 12.32% | -32,2 -29,4 -9.5% | -31,8 -32,5 2.19% | -32,7 -32,0 -1.96% | -34,1 -27,5 -23.85% | -38,4 -28,0 -37.15% | -37,0 | -41,7 | -43,6 | -44,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,6 -20,5 -24.74% | -21,0 -29,2 28.09% | -21,0 -26,3 20.12% | -18,3 -28,1 35.08% | -30,8 -27,9 -10.71% | -24,1 -32,1 24.89% | -28,1 -31,2 9.67% | -33,3 -21,5 -54.84% | -32,1 -20,3 -58.65% | -32,8 | -40,1 | -42,0 | -43,3 |
|
Net income Million USD | Released Forecast Spread | -25,7 -20,5 -25.22% | -21,2 -29,2 27.41% | -21,0 -26,3 20.1% | -18,4 -28,1 34.63% | -30,9 -27,8 -11.08% | -24,2 -31,4 23% | -28,3 -31,2 9.04% | -33,4 -22,3 -49.93% | -32,5 -20,3 -60.6% | -32,1 | -38,5 | -40,5 | -41,9 |
|
EPS USD | Released Forecast Spread | -0,61 -0,50 -23.23% | -0,50 -0,69 27.01% | -0,50 -0,61 17.65% | -0,43 -0,65 33.96% | -0,73 -0,62 -18.38% | -0,57 -0,69 17.54% | -0,62 -0,70 11.74% | -0,67 -0,46 -47.25% | -0,53 -0,36 -46.64% | -0,48 | -0,57 | -0,59 | -0,60 |
| Announcement Date | 24/02/22 | 10/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 11/05/23 | 03/08/23 | 02/11/23 | 29/02/24 | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for COMPASS Pathways plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CMPS Stock
- Calendar COMPASS Pathways plc
